ArticleBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2024

Can Endangered Biosimilar Markets be Rescued? The Need to Bridge Competing Interests for Long-Term Gain.

Teresa Barcina Lacosta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.